Halpern, A., Othus, M., Percival, M., Ghiuzeli, C. M., Appelbaum, J., Hendrie, P., Cassaday, R., Scott, B., Cooper, J., Keel, S., Oehler, V., Orozco, J., Russell, K., Mawad, R., Walter, R. (2025). A randomized phase 2 trial of CPX-351 vs. CLAG-m (Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone) in medically less-fit adults with previously untreated acute myeloid leukemia (AML) or other high-grade myeloid neoplasms. Blood. https://doi.org/10.1182/blood-2025-1663